Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
Core EBITDA Margin

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 20.0316.6416.7124.4016.95

What is the latest Core EBITDA Margin ratio of MARKSANS PHARMA ?

The latest Core EBITDA Margin ratio of MARKSANS PHARMA is 20.03 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202420.03
Mar202316.64
Mar202216.71
Mar202124.40
Mar202016.95

How is Core EBITDA Margin of MARKSANS PHARMA Trending?

Years Core EBITDA Margin % Change
Mar2024 20.03
20.37
Mar2023 16.64
-0.42
Mar2022 16.71
-31.52
Mar2021 24.4
43.95
Mar2020 16.95 -

Other Financial Ratios of MARKSANS PHARMA


Compare Core EBITDA Margin ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹13,485.0 Cr 3.6% -13.8% 85.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹443,661.0 Cr -1.8% 2.7% 49.1% Stock Analytics
DIVIS LABORATORIES ₹160,496.0 Cr -0.2% -3.4% 57% Stock Analytics
CIPLA ₹121,970.0 Cr -0.7% 0.6% 22.9% Stock Analytics
DR REDDYS LABORATORIES ₹112,877.0 Cr -1.8% 11.3% 18% Stock Analytics
ZYDUS LIFESCIENCES ₹98,163.2 Cr 1.9% 0.5% 41.9% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

3.6%

-13.8%

85.3%

SENSEX

0.7%

-2%

9.7%


You may also like the below Video Courses